Pulmonary delivery of magnolol-loaded nanostructured lipid carriers for COPD treatment
Chronic obstructive pulmonary disease (COPD) is a prevalent lung condition characterized by airflow obstruction, disability, and high mortality rates. Magnolol (MA), known for its anti-inflammatory and antioxidant properties, holds the potential for alleviating COPD symptoms. However, MA faces…
Read More...
Read More...